There have been a lot of DePuy hip lawsuits that has been filed ever since the announcement of the DePuy hip replacement recall. apparently, many of the 93,000 patients that have been implanted by the faulty hip replacement devices believes that the only way to get even for all the damages and losses that the device has caused them is to file necessary DePuy hip class action against the manufacturing company of the device.
The recall of two of the hip replacement products of DePuy, namely the DePuy ASR hip resurfacing system and the DePuy ASR XL acetabular system was due to the high five year revision rate of the products. It has been reported that 12% or one out of eight of the patients who have been implanted by the ASR resurfacing system and 13 percent out one out of eight individuals who had received the ASR XL acetabular system is subject to a revision surgery after just five year from their initial hip replacement surgery. Basically, a revision surgery means that the device that currently exists inside your body will be removed and another hip replacement device will be implanted.
Although DePuy Orthopaedics Inc., the manufacturing company of the said defective hip replacement systems has offered to cover for the customary costs of the patients regarding the hip replacement recall there are some patients who believe that this is not enough and the only way for them to get proper and fair compensation is by filing the appropriate DePuy hip lawsuits against the manufacturing company.
Most of the hip lawsuits that are filed are claiming of design defect and marketing defect. The first claim states that the manufacturing company failed to the adequate testing and research regarding the product that is why it resulted to failure. On the other hand, the marketing defect claims states that DePuy Orthopaedics Inc. has failed to inform the public about the high revision rate of the device on a timely manner even if they already knew about it. There is enough evidence that can prove that DePuy has known about the high revision rate of its products but has failed to issue the recall until August 2010.
The claims that are filed against DePuy may vary from one case to another that is why it is also expected that the amount of compensation that each patient gets will be different depending on their circumstances.
